BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit ...

HSBC downgraded Align Technology (ALGN) to Hold from Buy with a price target of $170, down from $290. The firm adjusted ratings in medical ...

Germany-headquartered life science company Evotec on Thursday reported further significant progress in its strategic research ...

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the ...

Apps: Pre-built applications with intuitive interfaces enable business users across the organization to leverage AI ...

The proposed transaction values VERAXA Biotech AG at USD 1.64 billion with expected gross cash proceeds up to USD 253 million held in trust by Voyager Acquisition Corp.